AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JAN 7 - (NewsRx.com & NewsRx.net) -- U.K.-based biotechnology company Microscience has entered into a cooperative research and development agreement (CRADA) with the Naval Medical Research Center (NMRC).
The collaboration will evaluate preclinically what Microscience believes will be the first oral anthrax vaccine to enter human testing.
Under the CRADA Microscience will provide its proprietary spi-VEC delivery system which has been engineered to deliver anthrax antigens, either as protein or DNA, via an oral route. Dr. Les Baillie will evaluate a number of vaccine candidates using key models of efficacy already developed at the NMRC's laboratories in Silver Spring, Maryland.
Microscience believes that a novel oral anthrax vaccine, made possible by their spi-VEC delivery system, will offer significant ...
Source: HighBeam Research, U.K. company to work with U.S. Naval Medical Research Center on oral...